ARTICLE | Company News
Cambridge Biostability, National Institutes of Health drug delivery news
January 22, 2007 8:00 AM UTC
Cambridge Biostability disclosed a £119,000 ($233,000) grant it received from NIH last September to develop stable formulations of vaccines to prevent and treat malaria, tuberculosis and AIDS. Phase I...